201. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload
- Author
-
Lisa J. Anderson, S Holden, John Walker, CC Charrier, N Bunce, Bernard A. Davis, John B. Porter, David N. Firmin, Dudley J. Pennell, Beatrix Wonke, and Emma Prescott
- Subjects
Adult ,Male ,medicine.medical_specialty ,Liver Iron Concentration ,Pathology ,Iron Overload ,Adolescent ,Iron ,Cardiomyopathy ,Management of thalassemia ,chemistry.chemical_compound ,Ventricular Dysfunction, Left ,Internal medicine ,medicine ,Odds Ratio ,Humans ,Prospective Studies ,Hemochromatosis ,Ejection fraction ,medicine.diagnostic_test ,business.industry ,Myocardium ,beta-Thalassemia ,medicine.disease ,Magnetic Resonance Imaging ,Logistic Models ,chemistry ,Liver biopsy ,Heart failure ,Cardiology ,Female ,Cardiology and Cardiovascular Medicine ,business ,Deferiprone ,Cardiomyopathies - Abstract
Aims To develop and validate a non-invasive method for measuring myocardial iron in order to allow diagnosis and treatment before overt cardiomyopathy and failure develops.Methods and Results We have developed a new magnetic resonance T2-star (T2*) technique for the measurement of tissue iron, with validation to chemical estimation of iron in patients undergoing liver biopsy. To assess the clinical value of this technique, we subsequently correlated myocardial iron measured by this T2* technique with ventricular function in 106 patients with thalassaemia major. There was a significant, curvilinear, inverse correlation between iron concentration by biopsy and liver T2* (r=0(.)93, P
- Published
- 2002